Metabolomics study reveals systematic metabolic dysregulation and early detection markers associated with incident pancreatic cancer.
Wang S, Li M, Yan L, He M, Lin H, Xu Y, Wan Q, Qin G, Chen G, Xu M, Wang G, Qin Y, Luo Z, Tang X, Wang T, Zhao Z, Xu Y, Chen Y, Huo Y, Hu R, Ye Z, Dai M, Shi L, Gao Z, Su Q, Mu Y, Zhao J, Chen L, Zeng T, Yu X, Li Q, Shen F, Chen L, Zhang Y, Wang Y, Deng H, Liu C, Wu S, Yang T, Li D, Ning G, Wu T, Wang W, Bi Y, Lu J; 4C Study Group.
Wang S, et al. Among authors: dai m.
Int J Cancer. 2022 Apr 1;150(7):1091-1100. doi: 10.1002/ijc.33877. Epub 2021 Dec 9.
Int J Cancer. 2022.
PMID: 34792202